Owner-Operator Independent Drivers Association
DOTRulemakingDOT-OST-2025-0049

Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Fentanyl to the Department of Transportation’s Drug-Testing Panel; Harmonization with Certain Items in the HHS Mandatory Guidelines for Urine and Oral Fluid; and Technical Amendments

RIN
Last modified
Oct 20, 2025
Comment window
closed 284d ago
Owner-Operator Independent Drivers Association filings
1

Activity

Owner-Operator Independent Drivers Association filed 1 comment on this docket between Oct 20, 2025 and Oct 20, 2025. 10 other organizations filed here. The comment window closed 284d ago.

What Owner-Operator Independent Drivers Association filed (1)

Oct 20, 2025· Comment from Owner-Operator Independent Drivers Association (OOIDA)· DOT-OST-2025-0049-0109

Owner-Operator Independent Drivers Association (OOIDA) comments re: Addition of Fentanyl to DOT Drug-Testing Panel

Abstract

This rulemaking would adopt the drug testing panel identified by the U.S. Department of Health and Human Services (HHS) in their urine and oral fluid Mandatory Guidelines for Federal Workplace Drug Testing Programs by proposing to amend the Department of Transportation's Drug Testing Panel in 49 CFR Part 40 by adding Fentanyl and norfentanyl (Schedule II drugs). The rulemaking also proposes to 1) amend certain provisions of part 40 to harmonize, as appropriate, with the current HHS Mandatory Guidelines using urine (UrMG) and oral fluid (OFMG) and 2) clarify certain existing part 40 drug testing program provisions and to make technical amendments.

View on regulations.gov →